• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受细胞减灭术和腹腔热灌注化疗的患者中,与免疫抑制和术后感染相关的危险相关分子模式的血浆水平升高。

Increased Plasma Levels of Danger-Associated Molecular Patterns Are Associated With Immune Suppression and Postoperative Infections in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

机构信息

Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, Netherlands.

Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.

出版信息

Front Immunol. 2018 Apr 5;9:663. doi: 10.3389/fimmu.2018.00663. eCollection 2018.

DOI:10.3389/fimmu.2018.00663
PMID:29675023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5895648/
Abstract

INTRODUCTION

Danger-associated molecular patterns (DAMPs) can elicit immune responses and may subsequently induce an immune-suppressed state. Previous work showed that increased plasma levels of DAMPs are associated with immune suppression and increased susceptibility toward infections in trauma patients. Like trauma, major surgical procedures, such as cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC), are also thought to cause profound DAMP release. Furthermore, the incidence of postoperative infections in these patients, ranging from 10 to 36%, is very high compared to that observed in patients undergoing other major surgical procedures. We hypothesized that the double hit of surgical trauma (CRS) in combination with HIPEC causes excessive DAMP release, which in turn contributes to the development of immune suppression. To investigate this, we assessed DAMP release in patients undergoing CRS-HIPEC, and investigated its relationship with immune suppression and postoperative infections.

METHODS

In 20 patients undergoing CRS-HIPEC, blood was obtained at five time points: just before surgery (baseline), after CRS, after HIPEC, at ICU admission, and 1 day after surgery. Circulating levels of DAMPs [heat shock protein (HSP)70, high mobility group box (HMGB)1, S100A12, S100A8/S100A9, nuclear (n)DNA, mitochondrial (mt)DNA, lactate dehydrogenase (LDH), a marker of unscheduled cell death], and cytokines [tumor necrosis factor (TNF)α, IL-6, IL-8, IL-10, macrophage inflammatory protein (MIP)-1α, MIP-1β, and MCP-1] were measured. The extent of immune suppression was determined by measuring HLA-DR gene expression and leukocytic cytokine production capacity.

RESULTS

Plasma levels of DAMPs (maximum fold increases of HSP70: 2.1 [1.5-2.8], HMGB1: 5.9 [3.2-9.8], S100A8/S100A9: 3.6 [1.8-5.6], S100A12: 2.6 [1.8-4.3], nDNA 3.9 [1.0-10.8], LDH 1.7 [1.2-2.5]), and all measured cytokines increased profoundly following CRS-HIPEC. Evidence of immune suppression was already apparent during the procedure, illustrated by a decrease of HLA-DR expression compared with baseline (0.5-fold [0.3-0.9]) and diminished pro-inflammatory cytokine production capacity. The increase in HMGB1 levels correlated with the decrease in HLA-DR expression ( = -0.46,  = 0.04), and peak HMGB1 concentrations were significantly higher in the five patients who went on to develop a postoperative infection (p = 0.04).

CONCLUSION

CRS-HIPEC is associated with profound DAMP release and immune suppression, and plasma HMGB1 levels are related with the occurrence of postoperative infections in these patients.

摘要

介绍

危险相关分子模式(DAMPs)可以引发免疫反应,并可能随后诱导免疫抑制状态。先前的研究表明,DAMPs 血浆水平的升高与免疫抑制和创伤患者感染易感性增加有关。与创伤一样,大手术,如细胞减灭术(CRS)联合腹腔内热灌注化疗(HIPEC),也被认为会导致大量 DAMPs 的释放。此外,这些患者术后感染的发生率(10%至 36%)与其他大手术患者相比非常高。我们假设手术创伤(CRS)与 HIPEC 的双重打击会导致过度的 DAMPs 释放,从而导致免疫抑制的发展。为了研究这一点,我们评估了接受 CRS-HIPEC 的患者的 DAMPs 释放情况,并研究了其与免疫抑制和术后感染的关系。

方法

在 20 名接受 CRS-HIPEC 的患者中,在五个时间点采集血液:手术前(基线)、CRS 后、HIPEC 后、ICU 入院时和手术后 1 天。测量循环 DAMPs[热休克蛋白(HSP)70、高迁移率族蛋白(HMGB)1、S100A12、S100A8/S100A9、核(n)DNA、线粒体(mt)DNA、乳酸脱氢酶(LDH),一种非计划性细胞死亡的标志物]和细胞因子[肿瘤坏死因子(TNF)α、IL-6、IL-8、IL-10、巨噬细胞炎症蛋白(MIP)-1α、MIP-1β 和 MCP-1]的水平。通过测量 HLA-DR 基因表达和白细胞细胞因子产生能力来确定免疫抑制的程度。

结果

CRS-HIPEC 后 DAMPs 血浆水平(HSP70 的最大倍数增加:2.1[1.5-2.8]、HMGB1:5.9[3.2-9.8]、S100A8/S100A9:3.6[1.8-5.6]、S100A12:2.6[1.8-4.3]、nDNA:3.9[1.0-10.8]、LDH:1.7[1.2-2.5])和所有测量的细胞因子均显著增加。在手术过程中已经出现了免疫抑制的证据,与基线相比,HLA-DR 表达下降(0.5 倍[0.3-0.9])和促炎细胞因子产生能力下降。HMGB1 水平的增加与 HLA-DR 表达的降低相关(r=-0.46,p=0.04),并且在五个发生术后感染的患者中 HMGB1 浓度峰值明显更高(p=0.04)。

结论

CRS-HIPEC 与 DAMPs 的大量释放和免疫抑制有关,并且这些患者的血浆 HMGB1 水平与术后感染的发生有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae4/5895648/715b80fd38ea/fimmu-09-00663-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae4/5895648/254cbdd53c0f/fimmu-09-00663-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae4/5895648/da1213a95701/fimmu-09-00663-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae4/5895648/e38eb1c9d762/fimmu-09-00663-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae4/5895648/715b80fd38ea/fimmu-09-00663-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae4/5895648/254cbdd53c0f/fimmu-09-00663-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae4/5895648/da1213a95701/fimmu-09-00663-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae4/5895648/e38eb1c9d762/fimmu-09-00663-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae4/5895648/715b80fd38ea/fimmu-09-00663-g004.jpg

相似文献

1
Increased Plasma Levels of Danger-Associated Molecular Patterns Are Associated With Immune Suppression and Postoperative Infections in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.在接受细胞减灭术和腹腔热灌注化疗的患者中,与免疫抑制和术后感染相关的危险相关分子模式的血浆水平升高。
Front Immunol. 2018 Apr 5;9:663. doi: 10.3389/fimmu.2018.00663. eCollection 2018.
2
Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients.创伤患者血浆中危险相关分子模式水平与免疫抑制相关。
Intensive Care Med. 2016 Apr;42(4):551-561. doi: 10.1007/s00134-015-4205-3. Epub 2016 Feb 24.
3
Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.极限细胞减灭术与热灌注腹腔化疗:来自单一三级中心的结果
Surg Oncol. 2015 Sep;24(3):264-9. doi: 10.1016/j.suronc.2015.06.013. Epub 2015 Jun 23.
4
Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.热灌注腹腔化疗联合同期与分期细胞减灭术治疗隐匿性腹膜转移的胃癌
J Surg Oncol. 2015 Jun;111(7):840-7. doi: 10.1002/jso.23889. Epub 2015 Apr 10.
5
Clinical and predictive value of blood lactate levels during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a comparative analysis.在细胞减灭术和腹腔热灌注化疗(HIPEC)期间血液乳酸水平的临床和预测价值:比较分析。
Updates Surg. 2021 Feb;73(1):313-319. doi: 10.1007/s13304-020-00908-1. Epub 2020 Nov 4.
6
Histologic and Immunohistochemical Alterations Associated with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy.与肿瘤细胞减灭术和热灌注化疗相关的组织学及免疫组化改变
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S588-95. doi: 10.1245/s10434-015-4580-6. Epub 2015 May 7.
7
Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.细胞减灭术和腹腔内热化疗后腹膜恶性肿瘤患者的肠皮肤瘘:发病率、管理及结局
Surg Oncol. 2016 Sep;25(3):315-20. doi: 10.1016/j.suronc.2016.05.025. Epub 2016 May 24.
8
A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.一种用于预测减瘤手术联合热灌注腹腔化疗后主要并发症的新型工具。
Ann Surg Oncol. 2016 May;23(5):1609-17. doi: 10.1245/s10434-015-5012-3. Epub 2015 Dec 17.
9
Short-Term Postoperative Cognitive Dysfunction and Inflammatory Response in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Pilot Study.行细胞减灭术和腹腔内热灌注化疗的患者术后短期认知功能障碍与炎症反应:一项初步研究。
Mediators Inflamm. 2017;2017:3605350. doi: 10.1155/2017/3605350. Epub 2017 Nov 9.
10
Effects of Changes in the Levels of Damage-Associated Molecular Patterns Following Continuous Veno-Venous Hemofiltration Therapy on Outcomes in Acute Kidney Injury Patients With Sepsis.连续性静脉-静脉血液滤过治疗后损伤相关分子模式水平变化对脓毒症急性肾损伤患者结局的影响。
Front Immunol. 2019 Jan 7;9:3052. doi: 10.3389/fimmu.2018.03052. eCollection 2018.

引用本文的文献

1
Systematic Druggable-Proteome-Wide Mendelian Randomization Identifies Potential Therapeutic Targets for Allergic Conjunctivitis.全蛋白质组范围的系统性孟德尔随机化研究确定了过敏性结膜炎的潜在治疗靶点。
Transl Vis Sci Technol. 2025 Jul 1;14(7):6. doi: 10.1167/tvst.14.7.6.
2
Immediate postoperative effects of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using carboplatin on peritoneal tissue inflammatory and ischemic responses: an explorative porcine study.使用卡铂进行腹腔热灌注化疗的减瘤手术对腹膜组织炎症和缺血反应的术后即时影响:一项探索性猪研究
Pleura Peritoneum. 2025 Apr 22;10(2):69-80. doi: 10.1515/pp-2025-0001. eCollection 2025 Jun.
3

本文引用的文献

1
Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients.化疗后危险相关分子模式的释放不会导致白血病患者免疫麻痹。
Acta Haematol. 2017;138(1):39-43. doi: 10.1159/000477530. Epub 2017 Jul 20.
2
The immunopathology of sepsis and potential therapeutic targets.脓毒症的免疫病理学及潜在治疗靶点
Nat Rev Immunol. 2017 Jul;17(7):407-420. doi: 10.1038/nri.2017.36. Epub 2017 Apr 24.
3
Anti-inflammatory properties of anesthetic agents.麻醉剂的抗炎特性。
Anesthesia-induced developmental neurotoxicity in the setting of systemic inflammation: the role of microglia.
全身炎症背景下麻醉诱导的发育神经毒性:小胶质细胞的作用
Exp Biol Med (Maywood). 2025 May 16;250:10549. doi: 10.3389/ebm.2025.10549. eCollection 2025.
4
Inflammatory Markers and Postoperative New-Onset Atrial Fibrillation: Prognostic Predictions of Neutrophil Percent to Albumin Ratio in Patients with CABG.炎症标志物与术后新发房颤:冠状动脉旁路移植术患者中性粒细胞百分比与白蛋白比值的预后预测
Diagnostics (Basel). 2025 Mar 16;15(6):741. doi: 10.3390/diagnostics15060741.
5
The immunomodulatory effect of sugammadex in vitro and after total hip arthroplasty : A randomised controlled pilot and retrospective cohort study.舒更葡糖钠在体外及全髋关节置换术后的免疫调节作用:一项随机对照试验性及回顾性队列研究
Eur J Anaesthesiol. 2025 Aug 1;42(8):676-686. doi: 10.1097/EJA.0000000000002132. Epub 2025 Feb 14.
6
Association between cytokines and progression-free survival in ovarian cancer following CRS/HIPEC treatment.CRS/HIPEC治疗后卵巢癌中细胞因子与无进展生存期的关联
J Ovarian Res. 2025 Jan 7;18(1):3. doi: 10.1186/s13048-024-01586-y.
7
Postoperative Innate Immune Dysregulation, Proteomic, and Monocyte Epigenomic Changes After Colorectal Surgery: A Substudy of a Randomized Controlled Trial.结直肠手术后的术后先天性免疫失调、蛋白质组学及单核细胞表观基因组变化:一项随机对照试验的子研究
Anesth Analg. 2025 Jan 1;140(1):185-196. doi: 10.1213/ANE.0000000000007297. Epub 2024 Oct 25.
8
Phytocompounds-based therapeutic approach: Investigating curcumin and green tea extracts on MCF-7 breast cancer cell line.基于植物化合物的治疗方法:研究姜黄素和绿茶提取物对MCF-7乳腺癌细胞系的作用。
J Genet Eng Biotechnol. 2024 Mar;22(1):100339. doi: 10.1016/j.jgeb.2023.100339. Epub 2024 Jan 22.
9
The role of surgical tissue injury and intraoperative sympathetic activation in postoperative immunosuppression after breast-conserving surgery versus mastectomy: a prospective observational study.保乳手术与乳房切除术相比,手术组织损伤和术中交感神经激活在术后免疫抑制中的作用:一项前瞻性观察研究。
Breast Cancer Res. 2024 Mar 11;26(1):42. doi: 10.1186/s13058-024-01801-0.
10
Underneath Images and Robots, Looking Deeper into the Pneumoperitoneum: A Narrative Review.图像与机器人之下:深入探究气腹——一篇叙述性综述
J Clin Med. 2024 Feb 14;13(4):1080. doi: 10.3390/jcm13041080.
Crit Care. 2017 Mar 21;21(1):67. doi: 10.1186/s13054-017-1645-x.
4
Infectious Complications after Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy.肿瘤细胞减灭术及腹腔热灌注化疗后的感染性并发症
Surg Infect (Larchmt). 2017 Feb/Mar;18(2):157-163. doi: 10.1089/sur.2016.102. Epub 2016 Dec 1.
5
HMGB1 as biomarker and drug target.高迁移率族蛋白 B1 作为生物标志物和药物靶点。
Pharmacol Res. 2016 Sep;111:534-544. doi: 10.1016/j.phrs.2016.06.031. Epub 2016 Jul 1.
6
A review of 111 anaesthetic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.对111例接受减瘤手术和腹腔内热化疗的麻醉患者的回顾。
Singapore Med J. 2017 Aug;58(8):488-496. doi: 10.11622/smedj.2016078. Epub 2016 Apr 28.
7
Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients.创伤患者血浆中危险相关分子模式水平与免疫抑制相关。
Intensive Care Med. 2016 Apr;42(4):551-561. doi: 10.1007/s00134-015-4205-3. Epub 2016 Feb 24.
8
Targeting Hsp70: A possible therapy for cancer.靶向热休克蛋白70:一种可能的癌症治疗方法。
Cancer Lett. 2016 Apr 28;374(1):156-166. doi: 10.1016/j.canlet.2016.01.056. Epub 2016 Feb 17.
9
The human HSP70 family of chaperones: where do we stand?人类伴侣蛋白HSP70家族:我们目前的进展如何?
Cell Stress Chaperones. 2016 May;21(3):379-404. doi: 10.1007/s12192-016-0676-6. Epub 2016 Feb 10.
10
Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial.细胞减灭术及腹腔内化疗与全身化疗治疗结直肠癌腹膜转移的随机对照试验
Eur J Cancer. 2016 Jan;53:155-62. doi: 10.1016/j.ejca.2015.09.017. Epub 2016 Jan 2.